Showing results (1-10 of 129) with videos related to
Sort By:
Pageof 13
Organic Letters|September 25, 2009
A modular rearrangement approach toward medicinally relevant phosphinic structuresVassilis Rogakos, Dimitris Georgiadis, Vincent Dive, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 13, 2003
Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitorsAnastasios Makaritis, Dimitris Georgiadis, Vincent Dive, et al.The Journal of Organic Chemistry|August 25, 2007
A versatile annulation protocol toward novel constrained phosphinic peptidomimeticsMagdalini Nasopoulou, Dimitris Georgiadis, Magdalini Matziari, et al.Biochemistry|June 24, 2004
Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domainDimitris Georgiadis, Philippe Cuniasse, Jöel Cotton, et al.The FEBS Journal|April 21, 2006
Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzymeNicolas D Jullien, Philippe Cuniasse, Dimitris Georgiadis, et al.Journal of Medicinal Chemistry|November 11, 2009
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitorsNicolas Jullien, Anastasios Makritis, Dimitris Georgiadis, et al.Circulation Research|June 14, 2003
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitorsDimitris Georgiadis, Fabrice Beau, Bertrand Czarny, et al.The Journal of Biological Chemistry|February 17, 2006
Development of selective inhibitors and substrate of matrix metalloproteinase-12Laurent Devel, Vassilis Rogakos, Arnaud David, et al.Bioorganic & Medicinal Chemistry|September 16, 2008
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challengeDimitris Georgiadis, Athanasios YiotakisMolecular Aspects of Medicine|July 29, 2008
Synthetic active site-directed inhibitors of metzincins: achievement and perspectivesAthanasios Yiotakis, Vincent DivePageof 13